Pin Therapeutics

About:

Pin Therapeutics is a pharmaceutical startup focusing on advanced protein degradation therapeutics.

Website: https://www.pintherapeutics.com/

Top Investors: KOREA INVESTMENT & SECURITIES, Korea Development Bank, DSC Investment, Company K Partners, Korea Investment Partners

Description:

Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global pharma and biotech companies along with talented scientists both in Korea and USA. * Active Focus - PinE3: E3 ligase screening cascade for identifying novel warheads - PinGLUE: Assay cascade for molecular glue degrader screening * Programs - Selective Molecular Glue Degrader (CK1α) - Molecular Glue Degrader Programs (5-6 Undisclosed) - PROTAC Program (1 Undisclosed)

Total Funding Amount:

$34.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2017-02-01

Contact Email:

info(AT)pintherapeutics.com

Founders:

Hyunsun Jo

Number of Employees:

51-100

Last Funding Date:

2022-02-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai